NNE enters the final stretch before its August 14 earnings with the borrow market at its tightest in weeks, short interest near a quarter of the free float, and the stock down 39% in a month — a setup where the tension between bears and the nuclear energy narrative has rarely felt more acute.
The positioning picture is blunt: bears are deeply entrenched, and the lending pool has almost run dry. Short interest holds at 24.6% of the free float — up roughly 7% over the past month — and availability has collapsed to just 3.3%, down from 13.3% a week ago. That means for every share still available to borrow, roughly 29 are already lent out. The 52-week low availability reading is 0%, so this level is closer to maximum squeeze territory than comfortable. Cost to borrow, at 2.24%, has risen 34% over the past month but remains modest in absolute terms — it is not yet a prohibitive rate for short sellers, suggesting the shorts are dug in rather than being forced out. The ORTEX short score of 73.8 sits near the top of the universe, placing NNE in the 98th percentile for short-side pressure. Days to cover on FINRA's fortnightly print came in at 3.6 days — manageable but not trivial if momentum shifts.
Options positioning adds a mildly cautious layer. The put/call ratio has edged up to 0.55, running about 1.5 standard deviations above its 20-day average of 0.53 — not an extreme reading, but directionally consistent with a market hedging into the report. The 52-week PCR range runs from 0.36 to 0.80, so the current level sits closer to the defensive end without yet screaming panic.
The Street's view is divided and, frankly, wide. Truist Securities initiated coverage on July 14 with a Hold and a $22 target — roughly in line with where the stock trades now. Roth Capital came in earlier with a Buy and a $45 target. The consensus mean target of $41.40 implies substantial upside from $17.30, but two analysts is thin coverage for a stock of this profile, and targets that far apart tell you the range of outcomes is genuinely uncertain rather than just reflective of differing models. The EPS forward momentum score ranks in the 91st percentile on a 30-day basis — an unusually strong reading for a pre-revenue nuclear developer, likely driven by estimate revision dynamics rather than reported earnings. The price-to-book sits at 1.7x, compressing sharply, with the 30-day change in PB showing a near-0.8x contraction consistent with the stock's steep monthly decline.
Insider activity from early June is worth noting. CEO James Walker sold approximately $694,000 in aggregate across multiple transactions on June 3 and 5, while the CTO and CFO also trimmed modest positions. The largest single block came from I Financial Ventures Group, which sold roughly $1.94 million worth of shares across two transactions — significant given the firm holds around 15.8% of shares outstanding and has been reducing its position. None of these amounts to a fire sale relative to the company's capitalisation, and awards were granted alongside the sales, but the direction of insider flow is uniformly one way, with net insider selling of roughly $21.7 million in value over the past 90 days.
SMR, the closest correlated peer at 80%, jumped 9.4% on the day while NNE recovered just 5.4% — a gap worth watching, since persistent underperformance versus the sector name that trades most in lockstep with it has historically pointed to stock-specific pressure rather than theme rotation. The last NNE earnings print in May saw the stock fall 7.9% the following day and extend losses to 7.3% over the subsequent five sessions — a reminder that the report on August 14 has tended to resolve to the downside even when the nuclear energy theme is in favour.
The August 14 print is the clearest near-term focal point: with availability this tight, any gap move in either direction will be amplified, and the gap between the $22 Truist target and the $45 Roth target means the post-earnings narrative could pull analyst consensus sharply in one direction.
See the live data behind this article on ORTEX.
Open NNE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
